Download - Connect Innovate UK

KTN Ltd and the Health Community
Prof Mehdi Tavakoli, KTN Ltd
Achieving Patient Access to Highly Novel Medical and
Regenerative Technologies
Wednesday 9 April 2014
York
KTN Ltd and the Health Community
• On April 1st 2014 the current Knowledge Transfer Networks
merged to become a single company
• to better represent the interdisciplinary nature of innovation
• evolution not revolution
• Chris Warkup is the CEO of The KTN
• Sue Dunkerton part of senior leadership team
• Most Health KTN staff joined the new entity
KTN: Building a Healthy Nation
through Business Innovation
KTN Ltd supports business innovations through partnerships, access
to funding and knowledge transfer.
Connecting Partners
• Bringing together & facilitating collaborations with a common goal
Access to Funding
• Identify and influence new and existing sources of funding
Knowledge Transfer
• Opening doors to wider networks of people/organisations
UK Health Priority Areas
Emerging
Medical
Technologies
Novel
High Value
Manufacturing
Regenerative
Medicine
Synthetic
Biology
Detection and
Identification of
Infectious Agents
Assisted/
Independent
Living
Clinical Needs
Biopharmaceutical
& Bioprocessing
Therapies
Stratified
Medicine
Data and Digital
Healthcare
Health Community in Regen Med
•
•
•
•
Support community engagement activities across the breadth of the RegenMed sector
– Make links across priority areas and KTN communities : from bioprocessing to
transport to sensors to creative
– Industrially led Interest Groups Meetings eg:
• Cardiovascular
• Bioprocessing for Advanced Therapies
• Unmet Clinical Needs
– Clinical interactions
– Engagement with relevant RC funded centres: EPSRC, MRC
– Engage with UKRMP
– Support the ATMP manufacturing Community
– Work with CT Catapult
– Support Trade associations work eg BIA CTRMAC
Input to Gov’t led initiatives – BIS, DH, RMEG
Identify KT gaps and address by catalysing community building
Support development of partnerships involved in TSB funding
Supporting Organisations
International
National
Regional
Charities
Healthcare
UK
MediWales
UKTI
BIS
FCO-SIN
One Nucleus
European
BioTech
Network
NICE
Medilink UK
MHRA
Regener8
Companies
NISCHR
DH RMEG
NOCRI
Medilinks
KTN
(Health)
NIHR
FDA
IKC
TSB
ABHI/BIVD
A BIA/ABPI
European
Commission
BioNow
HTCs
DECs
BRCs/BRUs
Research
Councils
AHSN
Network
AHSNs
NHS Trusts/
Clinicians
Centres for Inn.
Manufacture
Universities
Doctoral Training
Centres
Finance for Innovation
Excellence in
Science
Framework 7
Leadership in KEITs
Cooperation
Health/NMP/ICT
EUROPE
H2020
www.FP7uk.co.uk
Business
Angels
Societal
Challenges
PPP’s
Innovation
Platforms
BioMedical Catalyst
TSB
Collaborative
R&D
Catapults
NATIONAL
www.innovateuk.org
Venture
Capitalists
KTP
SBRI
TSBSmart
Devolved Administrations/
Regional Funding
Smart: Scotland
Manufacturing
Advisory Service
(MAS)
R&D Grant:
Scotland
Regional Growth Funds
i4i
DoH/NIHR
RESEARCH COUNCILS
Case
Awards
HICF
HTCs
www.nihr-ccf.org.uk/site/programmes/i4i
www.rcuk.ac.uk
Responsive
Mode
Research
KTA
Private
Investors
Industrial
CASE
AWARDS
Managed
Programmes
IKCs
TECHNOLOGY READINESS LEVEL (TRL)
1
2
Basic Research
3
4
5
Applied Research
6
7
8
Commercialisation
9
What Happens next– how will we make an impact?
• KTN, Medical Technologies IKC and Regener8 worked together to
bring this meeting and community together
• The output of today with recommendations will be summarised
in a report that will be presented to the Regenerative Medicine
Expert Group in support of its work in this area
• RMEG will be hopefully view the delegate list from today as a
GO-TO community for further input, recommendation and
learning to support this workstream
• KTN and partners will work to continue connecting and
catalyse innovation
_connect portal
www.healthktn.org
www.innovateuk.org
THANK YOU
[email protected]
Priority Areas-Clinical Needs
• Identifying unmet clinical needs and influencing future
funding calls (eg TSB Reg Med 2014).
• Facilitating industry/clinicians collaborations through events.
• Identifying funding opportunities and collaborating partners.
• Access to leading clinicians and clinical centres of excellence.
• Close collaboration with DH, NHS, NIHR , NICE, NOCRI, NHS24, NISCHR , HSCNI and influencing future national
healthcare innovation strategy.
• Close collaborations with clinicians-led major initiatives e.g.
HTCs, DEC’s, AHSNs, BRCs, etc.
• Facilitating commercialisation of new products, accelerating
regulatory approvals and adoption by the NHS.
Clinicians/Industry Collaborations
Links to Clinicians-Health Technology
Cooperatives( HTC)
NHS Organisation
Cambridge University
Hospitals NHS Foundation
Trust
Sheffield Teaching
hospitals NHS Foundation
Trust
University Hospitals of
Birmingham NHS
Foundation Trust
Leeds Teaching Hospitals
NHS Trust
Clinical Area or Theme
Brain Injury - Several theme areas around brain injury of acquired and developmental
origin across the acute care pathway: acute care including bedside monitoring,
imaging, stem cells, genomic profiling and biomarkers.
Devices for Dignity - Urinary incontinence and management, renal technologies,
assistive and rehabilitative technologies.
Trauma Management - Four clinical themes, which mirror the patient journey:
Immediate Care, Secondary Care, Regeneration, Rehabilitation.
Colorectal Therapies - Minimally invasive therapies for colorectal disease with three
themes: Engineering, nanotechnology, biosensing.
Chronic gastrointestinal (GI) disease - Including prevention of stoma complications,
neuromodulation for faecal incontinence, novel diagnostics to stratify chronic GI
Barts Health NHS Trust
disease, improved safety and effectiveness of GI surgery.
Guy’s and St Thomas’ NHS Cardiovascular disease - Four themes: Artherosclerosis, Cardiac arrhythmias, Heart
Foundation Trust
failure and structural heart disease.
Bradford Teaching
Wound Prevention and Treatment - Wound management - patient led centralised
Hospitals NHS Foundation
wound research strategy.
Trust
Nottinghamshire
Mental Health and neurodevelopmental disorders - Attention Deficit Hyperactivity
Healthcare NHS Trust,
Disorder, Tourette’s Syndrome and autism, depression and bipolar disorder.
Institute of Mental Health
Healthcare Technology
Co-operatives (HTCs)
Colorectal Therapies HTC
Leeds Teaching Hospitals NHS Trust
.
Wound prevention and
treatment HTC
Bradford Teaching Hospitals NHS
Foundation Trust
.
Mental health and
neurodevelopmental
disorders HTC
Nottinghamshire Healthcare
NHS Trust, Institute of Mental
Health
Brain Injury HTC
Cambridge University Hospitals
NHS Foundation Trust
Devices for Dignity HTC
Sheffield Teaching Hospitals NHS
Foundation Trust
Chronic gastrointestinal
disease (enteric) HTC
Barts
Health NHS Trust
Trauma Management HTC
University Hospitals of Birmingham
NHS Foundation Trust
Cardiovascular disease
HTC
Guy’s and St Thomas’ NHS
Foundation Trust
Links to Clinicians-NIHR-Diagnostic
Evidence Co-operatives